Theralase Technologies Inc. announced the following leadership reorganization Effective November 15, 2021, Dr. Arkady Mandel, M.D., Ph.D., D.Sc., who is currently the Chief Scientific Officer (?CSO?) of the Company, will assume the role of Interim Chief Executive Officer (?CEO?), replacing Mr. John Trikola in the role of Interim CEO of the Company. Mr. Trikola has agreed to resign from his positions as the Chief Operating Officer and Interim CEO of the Company effective immediately, as a result of certain facts that have come to the Company?s attention concerning Mr. Trikola?s background that the Company?s vetting process failed to detect. The Company is currently taking steps to improve its vetting process for incoming officers and directors.